Dr. Dennis Poe is a professor in the department of Otolaryngology at Boston Children’s Hospital and Harvard Medical School, specializing in neurotology and skull base surgery. He attended medical school at State University of NY Upstate, residency at University of Chicago, and fellowship with Michael Glasscock, III in Nashville.  In 2011, he completed a PhD with Prof. Ilmari Pyykkö at the University of Tampere, Finland in Pathophysiology and Surgical Treatment of the Eustachian tube and postdoctoral work with the NanoEar European Union consortium on nanotechnology for targeted delivery of inner ear and middle ear therapy. He and his teams have worked to develop minimally invasive endoscopic surgical techniques for the ear.  Based on his research showing the cartilaginous Eustachian tube to be the site of most pathology where it serves as a functional valve, he has developed new diagnostic methods and procedures for Eustachian tube disorders.  He ran the International Eustachian Tube Study Group 2003 – 2024 and he is now the Honorary Past President of the International Working Group on Eustachian Tube.  He served as the principal investigator for the first multicenter clinical trial of balloon dilation of the Eustachian Tube that paved the road for FDA approval for the balloon dilation device, which represented a significant achievement as it became the first ever treatment, medical or surgical, to be approved by the FDA. This milestone opened the door for other medical and surgical treatments for ET disorders to follow.  He is the President-Elect for the American Otological Society 2026-2027.